Prestige Wealth Management Group’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$157K Sell
3,679
-892
-20% -$48.4K 0.03% 185
2026
Q1
$287K Sell
4,571
-169
-4% -$13.5K 0.06% 144
2025
Q4
$452K Buy
4,740
+4,240
+848% +$416K 0.09% 110
2025
Q3
$48.8K Buy
500
+14
+3% +$1.45K 0.01% 264
2025
Q2
$52.2K Sell
486
-21
-4% -$2.13K 0.01% 252
2025
Q1
$51.1K Sell
507
-200
-28% -$20.1K 0.01% 247
2024
Q4
$63.1K Sell
707
-1
-0.1% -$88 0.01% 237
2024
Q3
$59.3K Hold
708
0.01% 236
2024
Q2
$54.5K Sell
708
-5
-0.7% -$366 0.01% 217
2024
Q1
$48.8K Hold
713
0.01% 257
2023
Q4
$41.2K Sell
713
-99
-12% -$5.28K 0.01% 262
2023
Q3
$42.9K Hold
812
0.01% 256
2023
Q2
$43.9K Sell
812
-15
-2% -$783 0.01% 274
2023
Q1
$41.4K Buy
827
+7
+0.9% +$330 0.01% 259
2022
Q4
$37.9K Buy
820
+4
+0.5% +$173 0.01% 283
2022
Q3
$32K Buy
816
+61
+8% +$2.45K 0.01% 264
2022
Q2
$28K Sell
755
-48
-6% -$1.95K 0.01% 285
2022
Q1
$35K Buy
803
+81
+11% +$3.51K 0.01% 272
2021
Q4
$31K Buy
722
+5
+0.7% +$210 0.01% 306
2021
Q3
$31K Hold
717
0.01% 305
2021
Q2
$31K Sell
717
-36
-5% -$1.51K 0.01% 292
2021
Q1
$30K Buy
753
+222
+42% +$8.4K 0.01% 301
2020
Q4
$19K Buy
531
+34
+7% +$1.23K 0.01% 361
2020
Q3
$19K Hold
497
0.01% 356
2020
Q2
$18K Hold
497
0.01% 346
2020
Q1
$16K Buy
497
+191
+62% +$7.46K 0.01% 315
2019
Q4
$14K Sell
306
-7
-2% -$293 0.01% 321
2019
Q3
$13K Buy
313
+13
+4% +$551 0.01% 315
2019
Q2
$13K Hold
300
0.01% 304
2019
Q1
$12K Sell
300
-228
-43% -$8.71K 0.01% 321
2018
Q4
$19K Buy
+528
New +$19.1K 0.01% 314

Other funds holding BSX

Prestige Wealth Management Group's BSX Position: Q2 2026 in Review

Prestige Wealth Management Group reduced its Boston Scientific (BSX) stake by 20% in Q2 2026, selling an estimated $48.4K and leaving 3,679 shares worth $157K. The position accounts for 0.03% of the portfolio, ranked #185.

Prestige Wealth Management Group first reported a position in BSX in Q4 2018 and has held it in 31 quarters since. The position peaked at $452K in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Prestige Wealth Management Group held 3,679 shares of Boston Scientific worth $157K as of Q2 2026.
  • Prestige Wealth Management Group sold 892 Boston Scientific shares in Q2 2026, an estimated $48.4K.
  • Boston Scientific made up 0.03% of Prestige Wealth Management Group's portfolio in Q2 2026, its #185 holding.
  • Prestige Wealth Management Group first reported a position in Boston Scientific in Q4 2018 and has held it in 31 quarters since.
  • Prestige Wealth Management Group's Boston Scientific position peaked at $452K in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.